GeneOne Life Science

011000 · KOSPI · Health Care · SMALL CAP

[Amended] Rights offering (paid-in capital increase) decision (subsidiary)

Capital raise([Amended] Rights offering (paid-in capital increase) decision (subsidiary))· FILED 2026-06-15· RCEPT 20260615800004

About this filing

A decision to issue new shares (for cash, or free to existing shareholders), with the number of shares, the method and the use of proceeds.

Why companies file it: Share issues are disclosed because they change the share count.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-06-15, [Amended] Rights offering (paid-in capital increase) decision (subsidiary)
SourceDART rcept 20260615800004 → open original filing

Versions of this filing

  1. 2026-04-14Original
  2. 2026-04-30Amendment 1
  3. 2026-05-15Amendment 2
  4. 2026-06-15Amendment 3 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-15 (KST). · Converted at 1 USD ≈ ₩1,322 (rate of 2026-10-22).